reiter buy rate increas pt
encourag strong earn print like manag rais
revenu guidanc consensu outlook
view strong signal growth sustain larg
under-penetrated market clear align new product way
anticip help drive usag addit case vs
today dovetail thesi abl drive
increas convers bracket wire clear align
releas product expand applic continu view
invisalign platform best-in-class premium product tooth
align top pick within med-tech coverag univers
pleas see april initi report lead countri smile
detail
sale ep beat sale includ currenc
tailwind benefit align adjust fx revenu still handili
beat consensu match shipment
line model scanner servic revenu beat
us/consensu gross margin slightli higher street
better expect opex led oper margin vs
ep beat street
fx math pleas see exhibit detail
align busi hum new product launch way set
expand applic increas util invisalign key driver
behind growth project convert market clear
align bracket wire today algn product use
treat malocclus case estimate orthodont case start ww
upcom launch expect expand invisalign first
juli solut younger patient mix dentit mix
babi adult teeth help develop arch rapid palat
expand open opportun
consensu guidanc updat forecast
upward account result new outlook pleas see exhibit
 new project summari guidanc appli
ev/sal multipl new higher revenu estim result
price target previous
chang made note
buy chang
page analyst certif
perform rel
manufactur market clear align
therapi intra-or scanner cad cam
orthodont dental record storag
profit loss summari
growth margin
see room addit out-performance vs consensu
estim compani continu convert bracket
wire brace market toward clear align invisalign
platform monopolist posit close share
invisalign offer patient aesthet comfort solut
align teeth penetr clear align still singl
digit within total address market million orthodont
dentist check posit invisalign adopt even
competit like intensifi clear align field dentist
view invisalign cachet kleenex strong
brand sever orthodontist gener practition
spoke plan increas adopt technolog
come year give us convict
consensu sale estim achiev
chang net debt
average cost debt
risk invest thesi
competit come harder stronger expect new
entrant could also pressur significantli
model lead downward pressur oper margin
potenti macroeconom downturn chang
dental
reimburs could neg affect patient volume/margin
dentist willing purchas capit equip legal challeng
dont hold take resourc plan neg
impact compani abil open/maintain account
exhibit varianc estim
varianc estim
varianc estim
varianc estim
varianc estim
varianc
varianc
varianc
varianc
scanner servic
scanner servic
scanner servic
scanner servic
sale
scanner servic
sale
exhibit guidanc berenberg estim
sale
price target base revenue billion see upsid
potenti number justifi adopt higher multipl today
share trade premium forward sale vs group high-growth med-tech
peer vs group whose revenu increas averag
model sale growth given potenti upsid driver
revenu scarciti algn growth/profit combin rariti among hyper
growth med-tech stock believ stock warrant meaning premium peer
competit come harder stronger expect
although maintain close clear align market share first patent
issu compani begin expir could open door
increas competit particularli lower end product spectrum
straumann owner player clearcorrect share think could
face intens competit compani deeper pocket
main player bracket wire segment becom aggress
align system could limit algn convers opportun hinder
compani abil train addit dentist home print align repres
longer rang disrupt threat algn patient base could limit product adopt
technolog becom widespread avail immedi futur
new entrant could also pressur lead downward
pressur oper margin
factor downward price forecast believ price pressur
like affect low-end product repres smaller portion algn product mix
competit entrant offer lower price solut perceiv good
full invisalign platform could provid greater asp pressur potenti place
ep forecast risk
potenti macroeconom downturn chang
dental
unemploy trough great recess dental industri
suffer patient limit healthcar consumpt elect procedur
orthodont algn exposur limit given smaller sale footprint account
presenc time somewhat protect compani face full brunt
downturn today compani broader custom base would risk
potenti slowdown occur could neg impact revenu requir greater
level market invest drive increment case start
legal challeng dont hold take resourc
like compani signific ip portfolio litigi
year maintain know-how notabl compani current lawsuit
clearcorrect patent align scanner system
respect disput smiledirectclub emerg follow algn
announc entri creat brick mortar store front court take less
favor view patents/method contend dentist view
reput impact legal fight detriment could limit algn abil
differenti product acquir new account
profit loss account
net revenu
incom oper
incom oper
incom oper
incom oper
interest incom expens net
net incom provis incom tax equiti loss investe
provis incom tax
equiti loss investe net tax
incom oper
incom oper
incom oper
incom oper
sharecount dilut q/q quarter y/i annual
cash equival
prepaid expens current asset
properti plant equip net
goodwil intang asset net
total liabil stockhold equiti
total liabil stockhold equiti
total liabil stockhold equiti
total liabil stockhold equiti
oper
oper
oper
oper
depreci amort
net tax benefit stock-bas award
excess tax benefit share-bas payment arrang
equiti loss investe
chang asset liabil net effect acquisit
prepaid expens asset
accru long-term liabil
total chang work capit
net cash oper
net cash oper
net cash oper
net cash oper
invest
invest
invest
invest
acquisit net cash acquir
purchas pp
purchas market secur
proce matur market secur
proce sale market secur
loan advanc equiti investe
net cash invest
net cash invest
net cash invest
net cash invest
financ
financ
financ
financ
proce issuanc common stock
equiti forward contract relat asr
excess tax benefit share-bas payment arrang
employe tax paid upon vest rsu
net cash financ
net cash financ
net cash financ
net cash financ
net chang cash equival
net chang cash equival
net chang cash equival
net chang cash equival
 begin period
 end period
